Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07273799
PHASE3

Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia

Sponsor: Sheikh Zayed Federal Postgraduate Medical Institute

View on ClinicalTrials.gov

Summary

To compare the outcome of topical minoxidil 5% spray versus oral minoxidil 2.5 mg tablet for the treatment of androgenetic alopecia in males and females. Outcomes include efficacy of the treatment, measured by reduction in hair shedding, improvement in hair density and new hair growth as assessed by physican and patient assessment as well as safety, defined as incidence and severity of adverse events over a treatment period of 6 months

Key Details

Gender

All

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

200

Start Date

2025-12-20

Completion Date

2026-06-01

Last Updated

2025-12-10

Healthy Volunteers

No

Interventions

DRUG

Minoxidil 5 % Topical Spray

Topical spray on hairs

DRUG

minoxidil

Oral minoxidil 2.5mg

DRUG

Placebo Spray

placebo spray

DRUG

Placebo Tablet or Capsule

Placebo tablet